These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28803817)

  • 1. 6MWT can identify type 3 SMA patients with neuromuscular junction dysfunction.
    Pera MC; Luigetti M; Pane M; Coratti G; Forcina N; Fanelli L; Mazzone ES; Antonaci L; Lapenta L; Palermo C; Ranalli D; Granata G; Lomonaco M; Servidei S; Mercuri E
    Neuromuscul Disord; 2017 Oct; 27(10):879-882. PubMed ID: 28803817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatigue leads to gait changes in spinal muscular atrophy.
    Montes J; Dunaway S; Montgomery MJ; Sproule D; Kaufmann P; De Vivo DC; Rao AK
    Muscle Nerve; 2011 Apr; 43(4):485-8. PubMed ID: 21404286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Six-Minute Walk Test demonstrates motor fatigue in spinal muscular atrophy.
    Montes J; McDermott MP; Martens WB; Dunaway S; Glanzman AM; Riley S; Quigley J; Montgomery MJ; Sproule D; Tawil R; Chung WK; Darras BT; De Vivo DC; Kaufmann P; Finkel RS;
    Neurology; 2010 Mar; 74(10):833-8. PubMed ID: 20211907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A continuous repetitive task to detect fatigability in spinal muscular atrophy.
    Stam M; Wadman RI; Bartels B; Leeuw M; Westeneng HJ; Wijngaarde CA; van den Berg LH; van der Pol WL
    Orphanet J Rare Dis; 2018 Sep; 13(1):160. PubMed ID: 30208915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does albuterol have an effect on neuromuscular junction dysfunction in spinal muscular atrophy?
    Pera MC; Luigetti M; Sivo S; Lapenta L; Granata G; Antonaci L; Coratti G; Forcina N; Pane M; Mercuri E
    Neuromuscul Disord; 2018 Oct; 28(10):863-864. PubMed ID: 30177455
    [No Abstract]   [Full Text] [Related]  

  • 6. Gait assessment with solesound instrumented footwear in spinal muscular atrophy.
    Montes J; Zanotto D; Dunaway Young S; Salazar R; De Vivo DC; Agrawal S
    Muscle Nerve; 2017 Aug; 56(2):230-236. PubMed ID: 27863443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leg muscle function and fatigue during walking in spinal muscular atrophy type 3.
    Montes J; Dunaway S; Garber CE; Chiriboga CA; De Vivo DC; Rao AK
    Muscle Nerve; 2014 Jul; 50(1):34-9. PubMed ID: 24122959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six-minute walk test is reliable and valid in spinal muscular atrophy.
    Dunaway Young S; Montes J; Kramer SS; Marra J; Salazar R; Cruz R; Chiriboga CA; Garber CE; De Vivo DC
    Muscle Nerve; 2016 Nov; 54(5):836-842. PubMed ID: 27015431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nusinersen improves walking distance and reduces fatigue in later-onset spinal muscular atrophy.
    Montes J; Dunaway Young S; Mazzone ES; Pasternak A; Glanzman AM; Finkel RS; Darras BT; Muntoni F; Mercuri E; De Vivo DC; Bishop KM; Schneider E; Bennett CF; Foster R; Farwell W;
    Muscle Nerve; 2019 Oct; 60(4):409-414. PubMed ID: 31298747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysfunction of the neuromuscular junction in spinal muscular atrophy types 2 and 3.
    Wadman RI; Vrancken AF; van den Berg LH; van der Pol WL
    Neurology; 2012 Nov; 79(20):2050-5. PubMed ID: 23115209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ambulatory function in spinal muscular atrophy: Age-related patterns of progression.
    Montes J; McDermott MP; Mirek E; Mazzone ES; Main M; Glanzman AM; Duong T; Young SD; Salazar R; Pasternak A; Gee R; De Sanctis R; Coratti G; Forcina N; Fanelli L; Ramsey D; Milev E; Civitello M; Pane M; Pera MC; Scoto M; Day JW; Tennekoon G; Finkel RS; Darras BT; Muntoni F; De Vivo DC; Mercuri E
    PLoS One; 2018; 13(6):e0199657. PubMed ID: 29944707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limitations of 6-minute walk test reference values for spinal muscular atrophy.
    Goodwin AM; Cornett KMD; McKay MJ; Burns J; Garber CE; De Vivo DC; Montes J
    Muscle Nerve; 2020 Mar; 61(3):375-382. PubMed ID: 31884700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weakness and fatigue in diverse neuromuscular diseases.
    Montes J; Blumenschine M; Dunaway S; Alter AS; Engelstad K; Rao AK; Chiriboga CA; Sproule DM; De Vivo DC
    J Child Neurol; 2013 Oct; 28(10):1277-83. PubMed ID: 23847297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial Septal Defect, Neuromuscular Junction and Skeletal Abnormalities in Spinal Muscular Atrophy Type III.
    Luan XH; Liu J
    Chin Med J (Engl); 2017 Oct; 130(19):2382-2383. PubMed ID: 28937047
    [No Abstract]   [Full Text] [Related]  

  • 15. Protocol for a phase II, monocentre, double-blind, placebo-controlled, cross-over trial to assess efficacy of pyridostigmine in patients with spinal muscular atrophy types 2-4 (SPACE trial).
    Stam M; Wadman RI; Wijngaarde CA; Bartels B; Asselman FL; Otto LAM; Goedee HS; Habets LE; de Groot JF; Schoenmakers MAGC; Cuppen I; van den Berg LH; van der Pol WL
    BMJ Open; 2018 Jul; 8(7):e019932. PubMed ID: 30061431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statistical considerations in the study of spinal muscular atrophy. Dallas-Cincinnati-Newington Spinal Muscular Atrophy (DCN-SMA) Study Group.
    Buncher CR; Samaha F; Iannaccone ST; Russman BS; Cook JD; White M; McLaughlin C
    Muscle Nerve; 1990; 13 Suppl():S45-8. PubMed ID: 2233886
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical features of spinal muscular atrophy (SMA) type 3 (Kugelberg-Welander disease).
    Salort-Campana E; Quijano-Roy S
    Arch Pediatr; 2020 Dec; 27(7S):7S23-7S28. PubMed ID: 33357593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of X-linked bulbar and spinal muscular atrophy with impaired neuromuscular transmission].
    Kawakami O; Takano A; Tanaka A; Koike Y; Sobue G
    Rinsho Shinkeigaku; 1996 Jul; 36(7):892-4. PubMed ID: 8952360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlates of Fatigability in Patients With Spinal Muscular Atrophy.
    Bartels B; de Groot JF; Habets LE; Wadman RI; Asselman FL; Nieuwenhuis EES; van Eijk RPA; Goedee HS; van der Pol WL
    Neurology; 2021 Feb; 96(6):e845-e852. PubMed ID: 33219141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spinal muscular atrophy: survival pattern and functional status.
    Chung BH; Wong VC; Ip P
    Pediatrics; 2004 Nov; 114(5):e548-53. PubMed ID: 15492357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.